Literature DB >> 17616541

Cardiovascular risk models.

Luc Bonneux.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17616541      PMCID： PMC1925216          DOI： 10.1136/bmj.39262.643090.47

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Cholesterol-lowering therapy for smokers and non-smokers: a life-table analysis.

Authors:  L Bonneux
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

Review 2.  Alcohol and the risk of myocardial infarction.

Authors:  M Flesch; S Rosenkranz; E Erdmann; M Böhm
Journal:  Basic Res Cardiol       Date:  2001-04       Impact factor: 17.165

Review 3.  Functional foods for coronary heart disease risk reduction: a meta-analysis using a multivariate approach.

Authors:  Inar A Castro; Lúcia P Barroso; Patricia Sinnecker
Journal:  Am J Clin Nutr       Date:  2005-07       Impact factor: 7.045

Review 4.  Screening for breast cancer with mammography.

Authors:  P C Gøtzsche; M Nielsen
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 5.  Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review.

Authors:  Lee Hooper; Rachel L Thompson; Roger A Harrison; Carolyn D Summerbell; Andy R Ness; Helen J Moore; Helen V Worthington; Paul N Durrington; Julian P T Higgins; Nigel E Capps; Rudolph A Riemersma; Shah B J Ebrahim; George Davey Smith
Journal:  BMJ       Date:  2006-03-24

6.  How to measure the burden of mortality?

Authors:  L Bonneux
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

Review 7.  The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%.

Authors:  Oscar H Franco; Luc Bonneux; Chris de Laet; Anna Peeters; Ewout W Steyerberg; Johan P Mackenbach
Journal:  BMJ       Date:  2004-12-18

8.  Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.

Authors:  Julia Hippisley-Cox; Carol Coupland; Yana Vinogradova; John Robson; Margaret May; Peter Brindle
Journal:  BMJ       Date:  2007-07-05

9.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28

10.  Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease.

Authors:  I U Haq; P R Jackson; W W Yeo; L E Ramsay
Journal:  Lancet       Date:  1995-12-02       Impact factor: 79.321
View more
  2 in total

1.  Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study.

Authors:  Sophie Hill; Janet Spink; Dominique Cadilhac; Adrian Edwards; Caroline Kaufman; Sophie Rogers; Rebecca Ryan; Andrew Tonkin
Journal:  BMC Public Health       Date:  2010-03-04       Impact factor: 3.295

2.  Identifying individuals for primary cardiovascular disease prevention in UK general practice: priorities and resource implications.

Authors:  Tim A Holt; Margaret Thorogood; Frances Griffiths; Stephen Munday; David Stables
Journal:  Br J Gen Pract       Date:  2008-07       Impact factor: 5.386
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.